Export 133 results:
Filters: First Letter Of Last Name is F [Clear All Filters]
Yersinia pestis–etiologic agent of plague.. Clinical microbiology reviews. 10, 35–66.
(1997). VWA.
(2010). (2003). (2016).
Understanding the Cholera Epidemic, Haiti. Emerging Infectious Diseases. 11 number 7,
(2011). Understanding the cholera epidemic, Haiti. Emerging infectious diseases. 17, 1161.
(2011). Understanding Perceived Risk. (Schwing, R.., & Albers W., Ed.).Societal risk assessment: how safe is safe enough? New York:.
(1980). Type IV Pili, Transient Bacterial Aggregates, and Virulence of Enteropathogenic Escherichia coli. Science.. 280, 5372.
(1998). Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology.. 384, 1.
(2009). Toxoplasma gondii infections in cats from Paraná, Brazil: seroprevalence, tissue distribution, and biologic and genetic characterization of isolates. The Journal of Parasitology. 90,
(2004). The Response of Man to Virulent Shigella flexneri 2a. The Journal of Infectious Diseases. 119, 296–299.
(1969). (2012). Surveillance for waterborne disease outbreaks associated with drinking water—United States, 2011–2012. MMWR Morb Mortal Wkly Rep. 64, 842–8.
(2015). Spatio-temporal dynamics of cholera during the first year of the epidemic in Haiti. PLoS neglected tropical diseases. 7, e2145.
(2013). Soil survival of toxoplasma oocysts in Kansas and Costa Rica. The American Society of Tropical Medicine and Hygiene. 24,
(1975). Soil survival of toxoplasma oocysts in Kansas and Costa Rica. The American Society of Tropical Medicine and Hygiene. 24,
(1975). (2003). A sea change ahead for recreational water quality criteria. Journal of Water and Health. 7, 9–20.
(2009). SCID Mouse Model for Lethal Q Fever. Infection and Immunity. 71, 8.
(2003). Salmonella: from pathogenesis to therapeutics. Journal of Bacteriology. 189(5),
(2007). Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
(2000). Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
(2000). Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. Journal of Infectious Diseases. 128, 340–344.
(1973). Rocky Mountain spotted fever: a clinical dilemma. Curr. Clin. Top. Infect. Dis. 2, 89-108.
(1981).